2025年3月最新中科院分区数据已更新,欢迎查询使用。如果您对期刊系统有任何需求或者问题,欢迎
反馈给我们。近期推荐: | 热 SCI论文AI润色+人工QC服务 | 热 IF2.6,科学、技术与医学跨学科期刊征稿中 | 热 赛默飞基础学科研究有奖问卷 | 热 同行专家帮助选刊 |
![]() |
基本信息 | 登录收藏 | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名字![]() | Frontiers in Immunology FRONT IMMUNOL (此期刊被最新的JCR期刊SCIE收录) LetPub评分 7.7
144人评分
我要评分
声誉 7.6 影响力 7.1 速度 8.1 | |||||||||||||||||||||
期刊ISSN | 1664-3224 | 微信扫码收藏此期刊 | ||||||||||||||||||||
2023-2024最新影响因子 (数据来源于搜索引擎) | 5.7 点击查看影响因子趋势图 | |||||||||||||||||||||
实时影响因子 | 截止2025年5月19日:5.896 | |||||||||||||||||||||
2023-2024自引率 | 8.80%点击查看自引率趋势图 | |||||||||||||||||||||
五年影响因子 | 6.8 | |||||||||||||||||||||
JCI期刊引文指标 | 0.95 | |||||||||||||||||||||
h-index | 84 | |||||||||||||||||||||
CiteScore ( 2024年最新版) |
| |||||||||||||||||||||
期刊简介 |
| |||||||||||||||||||||
期刊官方网站 | http://journal.frontiersin.org/journal/immunology | |||||||||||||||||||||
期刊投稿格式模板 VIP专享 |
| |||||||||||||||||||||
期刊投稿网址 | http://www.frontiersin.org/submission/submissioninfo.aspx | |||||||||||||||||||||
期刊语言要求 | 经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件,不仅能满足Frontiers in Immunology的语言要求,还能让Frontiers in Immunology编辑和审稿人得到更好的审稿体验,让稿件最大限度地被Frontiers in Immunology编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务(包括SCI论文英语润色,同行资深专家修改润色,SCI论文专业翻译,SCI论文格式排版,专业学术制图等)帮助作者准备稿件,已助力全球15万+作者顺利发表论文。部分发表范例可查看:服务好评(5篇) 论文致谢(13篇) 。
提交文稿 | |||||||||||||||||||||
是否OA开放访问 | Yes | |||||||||||||||||||||
OA期刊相关信息![]() | 文章处理费:需要( USD3295; ) 文章处理费豁免:查看说明 其他费用:没有 期刊主题关键词:immunology、adaptive immunity、innate immunity、clinical immunology、molecular immunology 相关链接:Aims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review | |||||||||||||||||||||
通讯方式 | AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, SWITZERLAND, CH-1015 | |||||||||||||||||||||
出版商 | Frontiers Media S.A. | |||||||||||||||||||||
涉及的研究方向 | IMMUNOLOGY- | |||||||||||||||||||||
出版国家或地区 | SWITZERLAND | |||||||||||||||||||||
出版语言 | English | |||||||||||||||||||||
出版周期 | ||||||||||||||||||||||
出版年份 | 0 | |||||||||||||||||||||
年文章数 | 5971点击查看年文章数趋势图 | |||||||||||||||||||||
Gold OA文章占比 | 99.65% | |||||||||||||||||||||
研究类文章占比: 文章 ÷(文章 + 综述) | 71.28% | |||||||||||||||||||||
WOS期刊SCI分区 ( 2023-2024年最新版) | WOS分区等级:1区
| |||||||||||||||||||||
中国科学院《国际期刊预警 名单(试行)》名单 | 2025年03月发布的2025版:不在预警名单中 2024年02月发布的2024版:不在预警名单中 2023年01月发布的2023版:不在预警名单中 2021年12月发布的2021版:不在预警名单中 2020年12月发布的2020版:不在预警名单中 | |||||||||||||||||||||
中国科学院SCI期刊分区 ( 2025年3月最新升级版) | 点击查看中国科学院SCI期刊分区趋势图
| |||||||||||||||||||||
中国科学院SCI期刊分区 ( 2023年12月升级版) |
| |||||||||||||||||||||
中国科学院SCI期刊分区 ( 2022年12月旧的升级版) |
| |||||||||||||||||||||
SCI期刊收录coverage | Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE) Scopus (CiteScore) Directory of Open Access Journals (DOAJ) | |||||||||||||||||||||
PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1664-3224%5BISSN%5D | |||||||||||||||||||||
平均审稿速度 | 网友分享经验: 14 Weeks | |||||||||||||||||||||
平均录用比例 | 网友分享经验: | |||||||||||||||||||||
版面费/APC文章处理费信息 | 文章处理费:需要( USD3295; ) 文章处理费豁免:查看说明 其他费用:没有 LetPub提供文章处理费(APC)支持服务,可以用人民币支付版面费啦! | |||||||||||||||||||||
LetPub助力发表 | 经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍,平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务(包括SCI论文英语润色,同行资深专家修改润色,SCI论文专业翻译,SCI论文格式排版,专业学术制图等)后论文在Frontiers in Immunology顺利发表。
快看看作者怎么说吧:服务好评(5篇) 论文致谢(13篇) 。 提交文稿 | |||||||||||||||||||||
期刊常用信息链接 |
|
|
|
|
中国学者近期发表的论文 | |
1. | Effects of neutrophil granule proteins on sepsis-associated lymphopenia and their relationship with CD4+ T-cell pyroptosis Author: Mao, Jia-yu; Xie, Ya-wen; Lei, Xian-li; Zhang, Jia-hui; Cheng, Wei; Cui, Na Journal: FRONTIERS IN IMMUNOLOGY. 2025; Vol. 16, Issue , pp. -. DOI: 10.3389/fimmu.2025.1507800 PubMed DOI |
2. | The role of short-chain fatty acid in metabolic syndrome and its complications: focusing on immunity and inflammation Author: Yu, Wenqian; Sun, Siyuan; Fu, Qiang Journal: FRONTIERS IN IMMUNOLOGY. 2025; Vol. 16, Issue , pp. -. DOI: 10.3389/fimmu.2025.1519925 PubMed DOI |
3. | NOX4 modulates breast cancer progression through cancer cell metabolic reprogramming and CD8+ T cell antitumor activity Author: Xiong, Yingying; Weng, Yiming; Zhu, Shan; Qin, Jian; Feng, Jia; Jing, Xiaopeng; Luo, Chao; Gong, Wei; Sun, Rui; Peng, Min Journal: FRONTIERS IN IMMUNOLOGY. 2025; Vol. 16, Issue , pp. -. DOI: 10.3389/fimmu.2025.1534936 PubMed DOI |
4. | Multi-omics analysis reveals the sensitivity of immunotherapy for unresectable non-small cell lung cancer Author: Wu, Rui; Wei, Kunchen; Huang, Xingshuai; Zhou, Yinge; Feng, Xiao; Dong, Xin; Tang, Hao Journal: FRONTIERS IN IMMUNOLOGY. 2025; Vol. 16, Issue , pp. -. DOI: 10.3389/fimmu.2025.1479550 PubMed DOI |
5. | Manipulating the cGAS-STING Axis: advancing innovative strategies for osteosarcoma therapeutics Author: Li, Bingbing; Zhang, Cheng; Xu, Xiaojuan; Shen, Qiqin; Luo, Shunan; Hu, Junfeng Journal: FRONTIERS IN IMMUNOLOGY. 2025; Vol. 16, Issue , pp. -. DOI: 10.3389/fimmu.2025.1539396 PubMed DOI |
6. | Commensal bacteria education history calibrates the naivety and activation threshold of adaptive antiviral immune system Author: Li, Baohua; Sha, Zhou; Mou, Li; Zhang, Feng; Jia, Lifeng; Zhu, Yan; Guo, Yan; Deng, Guohong; Wu, Haibo; Wei, Hong; Wu, Yuzhang; Ye, Lilin; Liu, Changjiang; Li, Jian; Zhang, Yanyan Journal: FRONTIERS IN IMMUNOLOGY. 2025; Vol. 16, Issue , pp. -. DOI: 10.3389/fimmu.2025.1519023 PubMed DOI |
7. | Targeting Nrf2/KEAP1 signaling pathway using bioactive compounds to combat mastitis Author: Khan, Muhammad Zahoor; Li, Liangliang; Zhan, Yandong; Huang, Binjiang; Liu, Xiaotong; Kou, Xiyan; Khan, Adnan; Qadeer, Abdul; Ullah, Qudrat; Alzahrani, Khalid J.; Wang, Tongtong; Wang, Changfa; Zahoor, Muhammad Journal: FRONTIERS IN IMMUNOLOGY. 2025; Vol. 16, Issue , pp. -. DOI: 10.3389/fimmu.2025.1425901 PubMed DOI |
8. | Quantitative N-glycoproteomic analysis reveals glycosylation signatures of plasma immunoglobulin G in systemic sclerosis Author: Cheng, Lu; Li, Yanhong; Zhou, Yu; Ling, Yingying; Wu, Tong; Liang, Zongan; Wu, Yinlan; Tan, Chunyu; Liu, Yi; Zhang, Yong Journal: FRONTIERS IN IMMUNOLOGY. 2025; Vol. 16, Issue , pp. -. DOI: 10.3389/fimmu.2025.1531191 PubMed DOI |
9. | Successful sequential therapy with rituximab and telitacicept in refractory Anti-NMDA receptor encephalitis and MOG-associated demyelination: a case report and literature review Author: Zhang, Jingliang; Hu, Minzhe; Wang, Chunjuan; Guo, Shougang Journal: FRONTIERS IN IMMUNOLOGY. 2025; Vol. 16, Issue , pp. -. DOI: 10.3389/fimmu.2025.1509143 PubMed DOI |
10. | The absolute number of circulating Treg cells is reduced in difficult-to-treat RA patients and is ameliorated by low-dose IL-2 Author: Yan, Huanhuan; Zi, Xiaoyu; Yan, Huer; Zhang, Xiaoying; Bai, Jie; Gao, Chong; Li, Xiaofeng; Wang, Caihong Journal: FRONTIERS IN IMMUNOLOGY. 2025; Vol. 16, Issue , pp. -. DOI: 10.3389/fimmu.2025.1522893 PubMed DOI |
|
|
|
联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们
© 2010-2025 中国: LetPub上海 网站备案号:沪ICP备10217908号-1 沪公网安备号:31010402006960 (网站)31010405000484 (蝌蝌APP)
增值电信业务经营许可证:沪B2-20211595 网络文化经营许可证:沪网文[2023]2004-152号
礼翰商务信息咨询(上海)有限公司 办公地址:上海市徐汇区漕溪北路88号圣爱大厦1803室